Mayo Clinic selects U.K startup’s AI tool to gain insights on Covid’s effect on the heart

A U.K. startup — Ultromics, based in Oxford — is taking that effort into the world of echocardiography and last week won a major endorsement. The company’s AI software will now be used by Mayo Clinic in all its 10 echo labs in a research study, said Dr. Patricia Pellika, a cardiologist, and clinical researcher at Mayo Clinic, to gain a better understanding of how Covid-19 affects the heart. Pellika noted that it will be an international study and she has already seen interest from medical centers in other countries.